Creamer D, Hunt B J, Black M M
St John's Institute of Dermatology and Department of Haematology, St Thomas' Hospital, London SE1 7EH, U.K.
Br J Dermatol. 2000 Jun;142(6):1199-203. doi: 10.1046/j.1365-2133.2000.03550.x.
The antiphospholipid syndrome is an acquired prothrombotic state where thrombosis and/or pregnancy loss is related to the presence of antiphospholipid antibodies. Cutaneous necrosis secondary to intravascular thrombosis of small dermal vessels is a recognized but rare association with antiphospholipid syndrome. We report two patients with high circulating levels of anticardiolipin antibodies who developed widespread cutaneous necrosis as the first clinical manifestation of the antiphospholipid syndrome. The exact mechanism by which antiphospholipid antibodies mediate thrombosis is uncertain; however, proposed mechanisms of activity include endothelial cell activation, altered endothelial production of prostacyclin, activation of platelets, and modulation of the protein C and S pathways.
抗磷脂综合征是一种获得性血栓前状态,其中血栓形成和/或妊娠丢失与抗磷脂抗体的存在有关。小真皮血管血管内血栓形成继发的皮肤坏死是抗磷脂综合征一种已被认可但罕见的关联。我们报告了两名抗心磷脂抗体循环水平高的患者,他们出现广泛的皮肤坏死,作为抗磷脂综合征的首发临床表现。抗磷脂抗体介导血栓形成的确切机制尚不确定;然而,提出的作用机制包括内皮细胞活化、前列环素内皮生成改变、血小板活化以及蛋白C和S途径的调节。